221 related articles for article (PubMed ID: 19925656)
1. Initial activation of EpCAM cleavage via cell-to-cell contact.
Denzel S; Maetzel D; Mack B; Eggert C; Bärr G; Gires O
BMC Cancer; 2009 Nov; 9():402. PubMed ID: 19925656
[TBL] [Abstract][Full Text] [Related]
2. Nuclear signalling by tumour-associated antigen EpCAM.
Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
[TBL] [Abstract][Full Text] [Related]
3. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin.
Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS
Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903
[TBL] [Abstract][Full Text] [Related]
4. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
[TBL] [Abstract][Full Text] [Related]
5. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
Brown TC; Sankpal NV; Gillanders WE
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
[TBL] [Abstract][Full Text] [Related]
6. Regulated intramembrane proteolysis and degradation of murine epithelial cell adhesion molecule mEpCAM.
Hachmeister M; Bobowski KD; Hogl S; Dislich B; Fukumori A; Eggert C; Mack B; Kremling H; Sarrach S; Coscia F; Zimmermann W; Steiner H; Lichtenthaler SF; Gires O
PLoS One; 2013; 8(8):e71836. PubMed ID: 24009667
[TBL] [Abstract][Full Text] [Related]
7. MMP7 is a target of the tumour-associated antigen EpCAM.
Denzel S; Mack B; Eggert C; Massoner P; Stöcklein N; Kemming D; Harréus U; Gires O
Int J Exp Pathol; 2012 Oct; 93(5):341-53. PubMed ID: 22974215
[TBL] [Abstract][Full Text] [Related]
8. Nuclear EpICD expression and its role in hepatocellular carcinoma.
Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS
Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150
[TBL] [Abstract][Full Text] [Related]
9. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.
Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G
Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877
[TBL] [Abstract][Full Text] [Related]
10. EpCAM proteolysis: new fragments with distinct functions?
Schnell U; Kuipers J; Giepmans BN
Biosci Rep; 2013 Mar; 33(2):e00030. PubMed ID: 23409978
[TBL] [Abstract][Full Text] [Related]
11. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
[TBL] [Abstract][Full Text] [Related]
12. Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.
Fong D; Seeber A; Terracciano L; Kasal A; Mazzoleni G; Lehne F; Gastl G; Spizzo G
J Clin Pathol; 2014 May; 67(5):408-14. PubMed ID: 24465008
[TBL] [Abstract][Full Text] [Related]
13. EpCAM: another surface-to-nucleus missile.
Carpenter G; Red Brewer M
Cancer Cell; 2009 Mar; 15(3):165-6. PubMed ID: 19249674
[TBL] [Abstract][Full Text] [Related]
14. A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.
Tretter JY; Schorpp K; Luxenburger E; Trambauer J; Steiner H; Hadian K; Gires O; Niessing D
J Biol Chem; 2018 Jun; 293(23):8994-9005. PubMed ID: 29700109
[TBL] [Abstract][Full Text] [Related]
15. Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain.
Huang Y; Chanou A; Kranz G; Pan M; Kohlbauer V; Ettinger A; Gires O
J Biol Chem; 2019 Mar; 294(9):3051-3064. PubMed ID: 30598504
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.
Huang HP; Chen PH; Yu CY; Chuang CY; Stone L; Hsiao WC; Li CL; Tsai SC; Chen KY; Chen HF; Ho HN; Kuo HC
J Biol Chem; 2011 Sep; 286(38):33520-32. PubMed ID: 21799003
[TBL] [Abstract][Full Text] [Related]
17. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
Umemori K; Ono K; Eguchi T; Kawai H; Nakamura T; Ogawa T; Yoshida K; Kanemoto H; Sato K; Obata K; Ryumon S; Yutori H; Katase N; Okui T; Nagatsuka H; Ibaragi S
Oral Oncol; 2023 Jul; 142():106433. PubMed ID: 37236125
[TBL] [Abstract][Full Text] [Related]
18. EpCAM and the biology of hepatic stem/progenitor cells.
Dollé L; Theise ND; Schmelzer E; Boulter L; Gires O; van Grunsven LA
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G233-50. PubMed ID: 25477371
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM.
Munz M; Fellinger K; Hofmann T; Schmitt B; Gires O
Front Biosci; 2008 May; 13():5195-201. PubMed ID: 18508581
[TBL] [Abstract][Full Text] [Related]
20. EpCAM is involved in maintenance of the murine embryonic stem cell phenotype.
González B; Denzel S; Mack B; Conrad M; Gires O
Stem Cells; 2009 Aug; 27(8):1782-91. PubMed ID: 19544432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
